• European heart journal · May 1986

    Intraaortic balloon assistance in intractable cardiogenic shock.

    • S Moulopoulos, S Stamatelopoulos, and P Petrou.
    • Eur. Heart J. 1986 May 1;7(5):396-403.

    AbstractThe efficacy of intraaortic counterpulsation (IABP) in severe cardiogenic shock after acute myocardial infarction is questioned because of the lack of a large controlled series. Out of 52 patients treated for severe, prolonged cardiogenic shock 3 improved with 'conventional' treatment. Forty-nine patients did not improve and were in 'intractable' shock for an average of 10.74 +/- 7.14 h (means +/- SD). Of these, 34 were treated with IABP. Ten survived longer than a month. Of the remaining 15 patients of similar age, severity and duration of shock, in whom the balloon could not be made to operate, none survived. It is suggested that intraaortic counterpulsation can save a number of patients with severe protracted cardiogenic shock after all other available treatment modalities have failed.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.